Exploring IKKβ as an antiangiogenic therapeutic target in KRAS-induced lung cancer (2018)
Carneiro Lobo, Tatiana Correa; Santos, Edmilson Ozorio dos; Scalabrini, Luiza Coimbra; Cardeal, Laura Beatriz da Silva; Baldwin, Albert S; Giordano, Ricardo José 
; Bassères, Daniela Sanchez
Source: Translational Cancer Medicine. Conference titles: AACR International Conference on Translational Cancer Medicine. Unidade: IQ
Subjects: NEOPLASIAS PULMONARES, MUTAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARNEIRO LOBO, Tatiana Correa et al. Exploring IKKβ as an antiangiogenic therapeutic target in KRAS-induced lung cancer. Translational Cancer Medicine. Philadelphia: Instituto de Química, Universidade de São Paulo. Disponível em: http://clincancerres.aacrjournals.org/content/24/1_Supplement/B09. Acesso em: 15 nov. 2024. , 2018APA
Carneiro Lobo, T. C., Santos, E. O. dos, Scalabrini, L. C., Cardeal, L. B. da S., Baldwin, A. S., Giordano, R. J., & Bassères, D. S. (2018). Exploring IKKβ as an antiangiogenic therapeutic target in KRAS-induced lung cancer. Translational Cancer Medicine. Philadelphia: Instituto de Química, Universidade de São Paulo. Recuperado de http://clincancerres.aacrjournals.org/content/24/1_Supplement/B09NLM
Carneiro Lobo TC, Santos EO dos, Scalabrini LC, Cardeal LB da S, Baldwin AS, Giordano RJ, Bassères DS. Exploring IKKβ as an antiangiogenic therapeutic target in KRAS-induced lung cancer [Internet]. Translational Cancer Medicine. 2018 ; 24( 1):[citado 2024 nov. 15 ] Available from: http://clincancerres.aacrjournals.org/content/24/1_Supplement/B09Vancouver
Carneiro Lobo TC, Santos EO dos, Scalabrini LC, Cardeal LB da S, Baldwin AS, Giordano RJ, Bassères DS. Exploring IKKβ as an antiangiogenic therapeutic target in KRAS-induced lung cancer [Internet]. Translational Cancer Medicine. 2018 ; 24( 1):[citado 2024 nov. 15 ] Available from: http://clincancerres.aacrjournals.org/content/24/1_Supplement/B09
